PARIS (dpa-AFX) - Sanofi (SNYNF, SNY) and its animal health division Merial announced the U.S. FDA has approved NexGard Chewables for the treatment and prevention of flea infestations, and treatment and control of the American Dog tick in adult dogs and puppies, for one month.
NexGard will be a prescription-only product. Merial is planning to make NexGard available to veterinarians in time for the upcoming flea and tick season.
Copyright RTT News/dpa-AFX